Study of the Efficacy and Safety of RsqVD Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma
Clinical trial NCT02219178 · COMPLETED
Trial details
- NCT number
- NCT02219178
- Sponsor
- Cancer Trials Ireland
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-01
- Primary completion
- 2019-10-31
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.